Stocks
FibroGen (FGEN) EV/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -14.4 | -3.45 | -3.45 | -4.13 | -0.08 | -0.56 | ||
| Changes by years, y/y, % | -67% | -76% | 0% | +19% | -98% | -71.7% | |||
FibroGen. EV/EBITDA
FibroGen. EV/EBITDA, changes, %
FibroGen (FGEN) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EV/EBITDA | ? | -0.27 | 0.05 | -0.09 | -1.04 | -0.81 | -0.56 | |
| Changes by years, y/y, % | -91% | -102% | -98% | -79% | +200% | |||
| Changes by quarters, q/q, % | -95% | -118% | -278% | +1 120% | -23% | |||
